Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Nanjo

Showing results (71-80 of 117) with videos related to

Pageof 12
Sort By:
Diabetes Research (Edinburgh, Scotland)|August 1, 1989
Hemoglobin A1 in cirrhosis of the liverY Nomura, K Nanjo, M Miyano, et al.
Experimental Neurology|August 1, 1997
The absence of synergism between the effects of an aldose reductase inhibitor, epalrestat, and a vasodilator, cilostazol, on the nerve conduction slowing and the myelinated fiber atrophy in streptozotocin-induced diabetic ratsH Sasaki, K Naka, Y Kishi, et al.
Endocrine Journal|January 9, 1999
Characterization of the promoter of the mouse prohormone convertase PC2 geneS Ohagi, H Tatsuta, T Sanke, et al.
Diabetes Research and Clinical Practice|December 1, 1995
Effects of cilostazol on development of experimental diabetic neuropathy: functional and structural studies, and Na+ -K+ -ATPase acidity in peripheral nerve in rats with streptozotocin-induced diabetesK Naka, H Sasaki, Y Kishi, et al.
Diabetes Care|June 1, 1990
Lessons learned from molecular biology of insulin-gene mutationsD F Steiner, H S Tager, S J Chan, et al.
Radioisotopes|June 1, 1984
[Experimental and clinical evaluation of a pancreatic secretory trypsin inhibitor radioimmunoassay kit]T Sanke, M Kondo, E Satogami, et al.
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|May 10, 1996
[First case of Japanese spotted fever in Wakayama prefecture in Japan]T Yanagawa, K Machida, T Nishi, et al.
Diabetologia|February 1, 1991
Plasma islet amyloid polypeptide (Amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patientsT Sanke, T Hanabusa, Y Nakano, et al.
The American Journal of Pathology|December 7, 2000
S20G mutant amylin exhibits increased in vitro amyloidogenicity and increased intracellular cytotoxicity compared to wild-type amylinS Sakagashira, H J Hiddinga, K Tateishi, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|May 29, 2002
Sequence analysis of the pro-opiomelanocortin (POMC) gene in obese/diabetic JapaneseY Ohshiro, K Ueda, H Wakasaki, et al.
Pageof 12

Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
Diabetes Research (Edinburgh, Scotland)|August 1, 1989
Hemoglobin A1 in cirrhosis of the liverY Nomura, K Nanjo, M Miyano, et al.
Experimental Neurology|August 1, 1997
The absence of synergism between the effects of an aldose reductase inhibitor, epalrestat, and a vasodilator, cilostazol, on the nerve conduction slowing and the myelinated fiber atrophy in streptozotocin-induced diabetic ratsH Sasaki, K Naka, Y Kishi, et al.
Endocrine Journal|January 9, 1999
Characterization of the promoter of the mouse prohormone convertase PC2 geneS Ohagi, H Tatsuta, T Sanke, et al.
Diabetes Research and Clinical Practice|December 1, 1995
Effects of cilostazol on development of experimental diabetic neuropathy: functional and structural studies, and Na+ -K+ -ATPase acidity in peripheral nerve in rats with streptozotocin-induced diabetesK Naka, H Sasaki, Y Kishi, et al.
Diabetes Care|June 1, 1990
Lessons learned from molecular biology of insulin-gene mutationsD F Steiner, H S Tager, S J Chan, et al.
Radioisotopes|June 1, 1984
[Experimental and clinical evaluation of a pancreatic secretory trypsin inhibitor radioimmunoassay kit]T Sanke, M Kondo, E Satogami, et al.
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|May 10, 1996
[First case of Japanese spotted fever in Wakayama prefecture in Japan]T Yanagawa, K Machida, T Nishi, et al.
Diabetologia|February 1, 1991
Plasma islet amyloid polypeptide (Amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patientsT Sanke, T Hanabusa, Y Nakano, et al.
The American Journal of Pathology|December 7, 2000
S20G mutant amylin exhibits increased in vitro amyloidogenicity and increased intracellular cytotoxicity compared to wild-type amylinS Sakagashira, H J Hiddinga, K Tateishi, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|May 29, 2002
Sequence analysis of the pro-opiomelanocortin (POMC) gene in obese/diabetic JapaneseY Ohshiro, K Ueda, H Wakasaki, et al.
Pageof 12